5-(1-ethylpyrazol-4-yl)-3-(2H-pyrazolo[3,4-b]pyridin-3-ylmethyl)triazolo[4,5-b]pyrazine;3-(indolizin-6-ylmethyl)-5-[1-(isocyanomethyl)pyrazol-4-yl]triazolo[4,5-b]pyrazine;3-(indolizin-6-ylmethyl)-5-(1-propan-2-ylpyrazol-4-yl)triazolo[4,5-b]pyrazine;3-(indolizin-6-ylmethyl)-5-[1-(2,2,2-trifluoroethyl)pyrazol-4-yl]triazolo[4,5-b]pyrazine;3-[(1S)-1-[3-(methoxymethyl)indolizin-6-yl]ethyl]-5-(1-methylpyrazol-4-yl)-1,2-dihydrotriazolo[4,5-b]pyrazine;5-(1-methylpyrazol-4-yl)-3-[[3-(propan-2-yloxymethyl)indolizin-6-yl]methyl]triazolo[4,5-b]pyrazine
C112H102F3N51O2 — CID 158883797
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(1-ethylpyrazol-4-yl)-3-(2H-pyrazolo[3,4-b]pyridin-3-ylmethyl)triazolo[4,5-b]pyrazine;3-(indolizin-6-ylmethyl)-5-[1-(isocyanomethyl)pyrazol-4-yl]triazolo[4,5-b]pyrazine;3-(indolizin-6-ylmethyl)-5-(1-propan-2-ylpyrazol-4-yl)triazolo[4,5-b]pyrazine;3-(indolizin-6-ylmethyl)-5-[1-(2,2,2-trifluoroethyl)pyrazol-4-yl]triazolo[4,5-b]pyrazine;3-[(1S)-1-[3-(methoxymethyl)indolizin-6-yl]ethyl]-5-(1-methylpyrazol-4-yl)-1,2-dihydrotriazolo[4,5-b]pyrazine;5-(1-methylpyrazol-4-yl)-3-[[3-(propan-2-yloxymethyl)indolizin-6-yl]methyl]triazolo[4,5-b]pyrazine
5-(1-ethylpyrazol-4-yl)-3-(2H-pyrazolo[3,4-b]pyridin-3-ylmethyl)triazolo[4,5-b]pyrazine;3-(indolizin-6-ylmethyl)-5-[1-(isocyanomethyl)pyrazol-4-yl]triazolo[4,5-b]pyrazine;3-(indolizin-6-ylmethyl)-5-(1-propan-2-ylpyrazol-4-yl)triazolo[4,5-b]pyrazine;3-(indolizin-6-ylmethyl)-5-[1-(2,2,2-trifluoroethyl)pyrazol-4-yl]triazolo[4,5-b]pyrazine;3-[(1S)-1-[3-(methoxymethyl)indolizin-6-yl]ethyl]-5-(1-methylpyrazol-4-yl)-1,2-dihydrotriazolo[4,5-b]pyrazine;5-(1-methylpyrazol-4-yl)-3-[[3-(propan-2-yloxymethyl)indolizin-6-yl]methyl]triazolo[4,5-b]pyrazine (PubChem CID 158883797) has the molecular formula C112H102F3N51O2 and a molecular weight of 2251.40 g/mol. Its IUPAC name is 5-(1-ethylpyrazol-4-yl)-3-(2H-pyrazolo[3,4-b]pyridin-3-ylmethyl)triazolo[4,5-b]pyrazine;3-(indolizin-6-ylmethyl)-5-[1-(isocyanomethyl)pyrazol-4-yl]triazolo[4,5-b]pyrazine;3-(indolizin-6-ylmethyl)-5-(1-propan-2-ylpyrazol-4-yl)triazolo[4,5-b]pyrazine;3-(indolizin-6-ylmethyl)-5-[1-(2,2,2-trifluoroethyl)pyrazol-4-yl]triazolo[4,5-b]pyrazine;3-[(1S)-1-[3-(methoxymethyl)indolizin-6-yl]ethyl]-5-(1-methylpyrazol-4-yl)-1,2-dihydrotriazolo[4,5-b]pyrazine;5-(1-methylpyrazol-4-yl)-3-[[3-(propan-2-yloxymethyl)indolizin-6-yl]methyl]triazolo[4,5-b]pyrazine.
Molecular Properties
| Compound Name | 5-(1-ethylpyrazol-4-yl)-3-(2H-pyrazolo[3,4-b]pyridin-3-ylmethyl)triazolo[4,5-b]pyrazine;3-(indolizin-6-ylmethyl)-5-[1-(isocyanomethyl)pyrazol-4-yl]triazolo[4,5-b]pyrazine;3-(indolizin-6-ylmethyl)-5-(1-propan-2-ylpyrazol-4-yl)triazolo[4,5-b]pyrazine;3-(indolizin-6-ylmethyl)-5-[1-(2,2,2-trifluoroethyl)pyrazol-4-yl]triazolo[4,5-b]pyrazine;3-[(1S)-1-[3-(methoxymethyl)indolizin-6-yl]ethyl]-5-(1-methylpyrazol-4-yl)-1,2-dihydrotriazolo[4,5-b]pyrazine;5-(1-methylpyrazol-4-yl)-3-[[3-(propan-2-yloxymethyl)indolizin-6-yl]methyl]triazolo[4,5-b]pyrazine |
|---|---|
| PubChem CID | 158883797 |
| Molecular Formula | C112H102F3N51O2 |
| Molecular Weight | 2251.40 g/mol |
| Exact Mass | 2249.94 |
| IUPAC Name | 5-(1-ethylpyrazol-4-yl)-3-(2H-pyrazolo[3,4-b]pyridin-3-ylmethyl)triazolo[4,5-b]pyrazine;3-(indolizin-6-ylmethyl)-5-[1-(isocyanomethyl)pyrazol-4-yl]triazolo[4,5-b]pyrazine;3-(indolizin-6-ylmethyl)-5-(1-propan-2-ylpyrazol-4-yl)triazolo[4,5-b]pyrazine;3-(indolizin-6-ylmethyl)-5-[1-(2,2,2-trifluoroethyl)pyrazol-4-yl]triazolo[4,5-b]pyrazine;3-[(1S)-1-[3-(methoxymethyl)indolizin-6-yl]ethyl]-5-(1-methylpyrazol-4-yl)-1,2-dihydrotriazolo[4,5-b]pyrazine;5-(1-methylpyrazol-4-yl)-3-[[3-(propan-2-yloxymethyl)indolizin-6-yl]methyl]triazolo[4,5-b]pyrazine |
| SMILES | CC(C)OCc1ccc2ccc(Cn3nnc4ncc(-c5cnn(C)c5)nc43)cn12.CC(C)n1cc(-c2cnc3nnn(Cc4ccc5cccn5c4)c3n2)cn1.CCn1cc(-c2cnc3nnn(Cc4[nH]nc5ncccc45)c3n2)cn1.COCc1ccc2ccc([C@H](C)N3NNc4ncc(-c5cnn(C)c5)nc43)cn12.FC(F)(F)Cn1cc(-c2cnc3nnn(Cc4ccc5cccn5c4)c3n2)cn1.[C-]#[N+]Cn1cc(-c2cnc3nnn(Cc4ccc5cccn5c4)c3n2)cn1 |
| InChI | InChI=1S/C21H22N8O.C20H22N8O.C19H18N8.C18H13F3N8.C18H13N9.C16H14N10/c1-14(2)30-13-18-7-6-17-5-4-15(10-28(17)18)11-29-21-20(25-26-29)22-9-19(24-21)16-8-23-27(3)12-16;1-13(14-4-5-16-6-7-17(12-29-3)27(16)11-14)28-20-19(24-25-28)21-9-18(23-20)15-8-22-26(2)10-15;1-13(2)26-12-15(8-21-26)17-9-20-18-19(22-17)27(24-23-18)11-14-5-6-16-4-3-7-25(16)10-14;19-18(20,21)11-28-10-13(6-23-28)15-7-22-16-17(24-15)29(26-25-16)9-12-3-4-14-2-1-5-27(14)8-12;1-19-12-26-11-14(7-21-26)16-8-20-17-18(22-16)27(24-23-17)10-13-4-5-15-3-2-6-25(15)9-13;1-2-25-8-10(6-19-25)12-7-18-15-16(20-12)26(24-23-15)9-13-11-4-3-5-17-14(11)22-21-13/h4-10,12,14H,11,13H2,1-3H3;4-11,13,25H,12H2,1-3H3,(H,21,24);3-10,12-13H,11H2,1-2H3;1-8,10H,9,11H2;2-9,11H,10,12H2;3-8H,2,9H2,1H3,(H,17,21,22)/t;13-;;;;/m.0..../s1 |
| InChIKey | JDIYQOSDZPHXHC-MYAIWQSWSA-N |
| XLogP | 15.14 |
| TPSA | 528.89 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 51 |
| Rotatable Bonds | 27 |
| Heavy Atoms | 168 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2251.40 |
| LogP ≤ 5 | 15.14 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 51 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158883797 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.